Effects of Quinapril on Myocardial Function, Ventricular Remodeling and Cardiac Cytokine Expression in Congestive Heart Failure in the Rat

[1]  H. Miller,et al.  Pathophysiological role of cytokines in congestive heart failure. , 2001, Annual review of medicine.

[2]  S. Anker,et al.  Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure , 2000, Circulation.

[3]  S. Yusuf,et al.  Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. , 1999, Circulation.

[4]  B. Bozkurt,et al.  Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. , 1999, Circulation.

[5]  M. Runge,et al.  Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. , 1999, Circulation research.

[6]  D. Mann,et al.  Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. , 1999, Circulation.

[7]  R. Cannon,et al.  Mechanism by which quinapril improves vascular function in coronary artery disease. , 1999, The American journal of cardiology.

[8]  B. Bozkurt,et al.  Safety and Efficacy of a Soluble P 75 Tumor Necrosis Factor Receptor ( Enbrel , Etanercept ) in Patients With Advanced Heart Failure , 1999 .

[9]  J. Egido,et al.  ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis. , 1998, The American journal of pathology.

[10]  J. Rouleau,et al.  Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat. , 1998, Circulation.

[11]  A. Ciampi,et al.  Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. , 1998, European heart journal.

[12]  中村 一文.  Inhibitory Effects of Antioxidants on Neonatal Rat Cardiac Myocyte Hypertrophy Induced by Tumor Necrosis Factor-α and Angiotensin II , 1998 .

[13]  K. Mihara,et al.  Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. , 1998, Circulation.

[14]  W. Colucci,et al.  New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress , 1998, The Lancet.

[15]  KohOno,et al.  Cytokine Gene Expression After Myocardial Infarction in Rat Hearts , 1998 .

[16]  A. Matsumori,et al.  Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. , 1998, Circulation.

[17]  C. Pepine.  Rationale for ACE inhibition as an anti-ischaemic therapy. , 1998, European heart journal.

[18]  M. Netea,et al.  The effect of renin–angiotensin system inhibitors on pro‐ and anti‐inflammatory cytokine production , 1998, Immunology.

[19]  M. Pfeffer,et al.  ACE inhibitors in acute myocardial infarction: patient selection and timing. , 1998, Circulation.

[20]  R. Peshock,et al.  Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α , 1998 .

[21]  F. Clubb,et al.  Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. , 1998, Circulation.

[22]  A. Moustapha,et al.  Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. , 1998, Circulation.

[23]  C. Thiemermann,et al.  Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone. , 1997, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[24]  A. Koretsky,et al.  Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .

[25]  H. Oral,et al.  Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. , 1997, Circulation research.

[26]  J. A. Bowers,et al.  Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. Prospective Randomized Amlodipine Survival Evaluation. , 1997, Journal of the American College of Cardiology.

[27]  B. Berk,et al.  Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. , 1997, Circulation research.

[28]  M. Satoh,et al.  Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. , 1997, Journal of the American College of Cardiology.

[29]  R. Kelly,et al.  Cytokines and cardiac contractile function. , 1997, Circulation.

[30]  D. Zechner,et al.  Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. , 1996, The Journal of clinical investigation.

[31]  D. Mann.  Stress activated cytokines and the heart. , 1996, Cytokine & growth factor reviews.

[32]  T. LeJemtel,et al.  Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. , 1996, Journal of the American College of Cardiology.

[33]  D. Mann,et al.  Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart , 1996 .

[34]  U. Ikeda,et al.  Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. , 1995, Circulation.

[35]  A. Ogata,et al.  Hypoxic stress induces cardiac myocyte-derived interleukin-6. , 1995, Circulation.

[36]  M. Ruzicka,et al.  Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy. , 1995, Circulation.

[37]  J. Rouleau,et al.  Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. , 1994, Journal of the American College of Cardiology.

[38]  G. Lamas,et al.  Quantitative Two-Dimensional Echocardiographic Measurements are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction: The Protective Effect of Captopril , 1994, Circulation.

[39]  S. Sclarovsky,et al.  Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction. , 1994, American heart journal.

[40]  J. Rouleau,et al.  Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias. , 1994, Journal of the American College of Cardiology.

[41]  L. Vaca,et al.  Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. , 1993, The Journal of clinical investigation.

[42]  C. Esmon,et al.  Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. , 1993, The Journal of clinical investigation.

[43]  J. Balligand,et al.  Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. , 1993, The Journal of clinical investigation.

[44]  F. Pagani,et al.  Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. , 1992, The Journal of clinical investigation.

[45]  Simon C Watkins,et al.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.

[46]  W. Fiers,et al.  Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. , 1991, The American journal of pathology.

[47]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[48]  G. Schreiner,et al.  Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C. Herzog,et al.  [Interleukin 1 and tumor necrosis factor]. , 1987, Zeitschrift fur Rheumatologie.

[50]  J. Laragh.  Endocrine mechanisms in congestive cardiac failure. Renin, aldosterone and atrial natriuretic hormone. , 1986, Drugs.

[51]  M. Pfeffer,et al.  Influence of Chronic Captopril Therapy on the Infarcted Left Ventricle of the Rat , 1985, Circulation research.